Author Archives: Scalper1

Gilead HCV Combo Hits In Trials, Could Broaden Market

Gilead Sciences (GILD) said Monday that its two-drug combo had succeeded against six different genotypes of the hepatitis C virus (HCV) in four late-stage clinical trials. Gilead’s studies combined sofosbuvir — which is sold separately as Sovaldi and is also an ingredient in Harvoni — with a new drug candidate called velpatasvir. Some cohorts took ribavirin, an older HCV pill, in place of velpatasvir. The patients on sofosbuvir/velpatasvir for 12

Tech Stocks On IBD 50 Power Up With Market Rebound

Monday morning’s rising stock market gave an outsized lift to some top-rated tech stocks. One of three techs returning to the IBD 50 list of top-rated growth stocks this week managed to buck Friday’s stock market selloff. SS&C Technologies Holdings (SSNC), a software maker for the financial services industry, lifted 0.6% for the day. But it and the other two were up notably in midday trading on the stock market today, SSNC by more than 1% while